Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Bioprocess Containers Market Report by Type (2D Container, 3D Container, Accessories), Application (Production Process, Upstream Process, Downstream Process), End User (Pharmaceutical Companies, Biotechnology Companies), and Region- Forecast till 2032

ID: MRFR/MED/5169-HCR | 100 Pages | Author: Kinjoll Dey| May 2024

Global Bioprocess Containers Market Overview

Bioprocess Containers market Size was valued at USD 1.90 billion in 2022 and is projected to grow from USD 2.40 Billion in 2023 to USD 10.01 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 26% during the forecast period (2023 - 2032).  The lower risk of cross-contamination and growing demand for biological products are the key market driver enhancing market growthBioprocess Containers MarketSource: Secondary Research, Primary Research, MRFR Database and Analyst Review

During the forecast period, interest in biologics and biosimilars is anticipated to propel the global market. The market is also being expanded by the move toward single-use technologies that enable quicker production deadlines. Another significant factor driving the growth of the international bioprocess containers market is the rise in the privatization of laboratory services. The major drivers of the market's expansion are the increasing incidences of cancer and immunological disorders around the world, which call for the use of vaccines and biologics, as well as their choice for immunotherapy and chemotherapy, which increases the demand for bioprocess containers. Therefore, the increased cancer burden and investment in medicines development are anticipated to fuel growth in the market under study. When producing diverse high-performance systems, bioprocess containers are easily incorporated.

As a result of the factors above, the requirement for bioprocess containers is anticipated to develop over the projected period. Additionally, vaccines are among the most significant types of biologics utilized for managing a variety of medical illnesses, and businesses are substantially investing in creating vaccinations for many diseases, including uncommon ones, which is further predicted to spur market expansion. High levels of sterility are necessary for creating biologics, including therapeutic vaccines, gene and cell therapies, and biologics produced using single-use tools and materials. The sum of these variables is anticipated to accelerate the market for bioprocess containers. Additionally, because creating and producing biologics is so expensive, businesses operating in the industry are increasingly exploring alternatives to conventional biological manufacturing techniques that are less expensive. Higher product yields are also possible thanks to developing innovative materials, bag layouts, and assembly methods for bioprocess containers. The possibilities of single-use technology are increasing as a result.


According to Thermo Fisher, its manufacturing facility in Lebanon, Tennessee, will bring materials closer to clients and is the main single-use bioproduction facility in its network. Thermo Fisher Scientific stated that the Greater Nashville plant will enable the company to meet rising demand for materials needed to produce vaccines and therapies for cancer and various other diseases. The $105 million expansion is part of a $650 million long-term investment the company stated last March. The Lebanon factory, located outside of Nashville, will produce fluid transfer assembly systems and customizable single-use bioprocess containers, both of which are in great demand by biopharmaceutical firms. This will guarantee a steady supply of essential components to produce vaccines and biopharmaceuticals.

Bioprocess Containers Market Trends

  • High development and manufacturing costs of biologics coupled with expiring patents should increase the market growth

Biologics currently account for nearly half of the oncology pharmacology market. Nearly 20 oncology biologic patents are set to expire by 2023. Biologic patent expiry is expected to delay the launch of biosimilars. The application of disposable systems in biosimilar development is expected to increase the demand for bioprocess containers. Thus, drving the market CAGR.

Biologics development, such as gene and cell therapies and therapeutic vaccines, requires high sterility, and biologics are increasingly manufactured with single-use consumables and equipment. All these factors are cumulatively expected to boost the growth of the Bioprocess Containers market. Furthermore, the cost of developing and manufacturing biologics is so high that companies operating in the market are increasingly looking for less expensive technologies than traditional biological manufacturing methods. Several biopharmaceutical manufacturers are incorporating disposable bioprocessing technologies into their development to produce cost-effective products. Thus it led to the expansion of bioprocess containers market revenue.

Figure 1: Bioprocess systems markets from 2013-2023 (in billion USD)Bioprocess systems markets from 2013-2023Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Factors such as eliminating the need for sterilization, increasing operational efficiency, and reducing manufacturing time for many pharmaceuticals rapidly increase the demand for single-use technologies, especially in biomanufacturing. At the same time, a reduction in manufacturing costs is expected to drive market growth. In addition, the sustainability and affordability of single-use bioprocess containers and reduced cross-contamination risk contribute to the market growth. However, the high cost of equipment may act as a hindrance to market growth. Moreover, introducing new drugs into the market is a significant growth opportunity.

Bioprocess Containers Market Segment Insights

Bioprocess Containers Type Insights

Based on the type, the Bioprocess Containers market segmentation includes 2D containers, 3D containers, and accessories. The 2D bioprocess containers segment held the majority share in 2022 for the Bioprocess Containers market revenue owing to its ability to accelerate existing biopharmaceutical manufacturing processes and the fact that it aids in media preparation, liquid management, and product storage.

2D bioprocess containers are widely used for cell harvesting, bulk drug and precursor delivery. Therefore, investments in developing and expanding biologics production are expected to increase the demand for 2D bioprocess containers, which is expected to drive the segment's growth. Several companies offer advanced 2D bioprocessing containers, including Thermo Fisher, CellBios, and Cole-Palmer.

February 2022: ALLpaQ Packaging Group has launched a new range of ALLpaQ 500 PLUS bioprocess containers. The company announced investments in bioprocess containers to lead the market and meet customer demands.

Bioprocess Containers Application Insights

The Bioprocess Containers market data has been bifurcated by application into upstream, downstream, and production processes. The upstream process segment dominated the market in 2022 due to the widespread use of bioprocess containers, especially during fermentation, mixing, and media processing. This contributes to the growth of the Bioprocess Containers market. Additionally, modern cell culture systems produce very high titers while reducing lab-to-production bioreactor time.

November 2021: Bionova opened a USD 25.0 million single-use plant in Fremont, California. The plant is equipped with a 1,000 L Cytiva XDR upstream train.

Bioprocess Containers  End Users Insights

The Bioprocess Containers market includes pharmaceutical and biotech companies based on end users. Pharmaceutical companies extensively use modern technology to combine single-use components into single-use unit operations, resulting in the potential integration of unit operations into single-use processes. This single-use within an aseptic process offers advantages for producing high-quality products without the risk of cross-contamination. Hence, rising End User options for Bio-process Containers positively impact market growth.

August 2022: Innovent Biologics of China and Paris-based Sanofi invested USD 2.42 billion in the biopharma group to jointly develop two cancer drugs in China.

Figure 2: Bioprocess Containers market by End-User, 2022 & 2030 (USD Billion)Bioprocess Containers market by End-User, 2022 & 2030Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


The innovative company maintains its vendor-agnostic strategy while leveraging its expertise to offer dependable process options in managing biopharmaceutical fluids. IRIS single-use bags are introduced to the biopharmaceutical sector by Single Use Support GmbH. IRIS single-use bags result from the company's considerable knowledge of how various single-use containers and assemblies behave throughout crucial steps like protection, filling and draining, freezing and thawing, preservation, and shipping of medicinal substances. All Single Use Support sterile consumables are branded with the initials IRIS, representing the company's core values of innovation, robustness, individuality, and single-use.

Bioprocess Containers Regional Insights

By region, the study offers market insights into Asia-Pacific, Europe, North America, and Rest of the World. The North America Bioprocess Containers market accounted for USD 0.87 billion in 2022 and is anticipated to exhibit a substantial CAGR growth during the study period, attributed to the high demand for biopharmaceuticals due to an aging population and advanced healthcare infrastructure in the United States. Also, the presence of major players focused on research activities, and huge investments in healthcare by US-based manufacturers contribute to its remarkable global market growth.

Further, the key countries studied in the market report are: The U.S, Canada, UK, Italy, Spain, Germany, France,  China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: BIOPROCESS CONTAINERS MARKET SHARE BY REGION 2022 (%)BIOPROCESS CONTAINERS MARKET SHARE BY REGION 2022Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Bioprocess Containers market accounts for the second-largest market share due to the increase in life science R&D companies and biologics manufacturing sectors. The extensive presence of biotech companies fuels the market's growth. Major European players are more focused development of innovative bioprocess containers to enhance operational efficiency, which also plays an important role in market growth. Additionally, increasing demand for biological products and biopharmaceuticals is boosting the growth of the bioprocess container market in the region. Moreover, UK Bioprocess Containers market held the largest market share, and the Germany Bioprocess Containers market was the fastest growing market in the Asia-Pacific region

The Asia-Pacific Life, Science Analytics Market, is anticipated to increase at the fastest CAGR from 2023 to 2030 due to the Increasing R&D activities, better pharmaceutical infrastructure, and relatively cheap labor costs driving the market growth. For example, in May 2017, Merck opened its first joint bioprocess scale-up lab with his Stelis Biopharma in Bangalore, India, providing an end-to-end solution for preclinical, clinical and commercial supply. Moreover, China Bioprocess Containers market held the largest market share, and the India Bioprocess Containers market was the fastest growing market in the Asia-Pacific region

Bioprocess Containers Key Market Players & Competitive Insights

Key market players are spending a large portion of money on research & development to increase their product lines, which will help the Bioprocess Containers market grow even more. Market players are also taking several strategic initiatives to increase their worldwide footprint, with key market developments such as mergers and acquisitions, contractual agreements, increased investments, new product launches, and collaboration with other organizations. Competitors in the Bioprocess Containers industry must expand their business footprint to survive in an increasingly competitive and rising market environment.

One of the manufacturers primary business strategies in the global Bioprocess Containers industry is to help clients and increase the market sector by increasing investment in R&D to enhance solutions and services. In recent years, the Bioprocess Containers industry has provided innovative solutions and reduced disruptions in the supply chain. The Bioprocess Containers markets major players such as Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), Meissner (US) and others are functioning on expanding the market demand by financing in research and development actions.

Thermo Fisher Scientific Inc. helps customers make the world healthier, cleaner and safer. It provides life science research, solving complex analytical challenges, increasing laboratory productivity, improving patient health through diagnostics, or developing and manufacturing life-changing therapeutics. It also offers an unrivaled combination of innovative technology, shopping convenience and pharmaceutical services through industry-leading brands such as Applied Biosystems, Thermo Scientific, Invitrogen, Unity Lab Services, Fisher Scientific, Patheon and PPD. For instance, In December 2020, Thermo Fisher introduced a 500 L capacity single-use bioreactor. Biopharmaceutical companies increasingly integrate single-use technology into perfusion and cGMP manufacturing processes.

Merck is a leading science and technology company. It is active in healthcare, life sciences and performance materials. Delivering gene-editing technology and discovering unique ways to treat the most challenging diseases enable intelligence in devices. For instance, in April 2020, Merck introduced the next component of the BioContinuum platform, the Bio4C software suite, creating a unique ecosystem that combines process control, analysis and plant-level automation. This innovative software suite allows users to see the entire manufacturing process.

Key Companies in the Bioprocess Containers market include

  • GE Healthcare (US)

  • Merck KGaA (Germany)

  • Thermo Fisher Scientific (US)

  • Sartorius (Germany)

  • Danaher Corporation (US)

  • Lonza (Switzerland)

  • Fenner PLC (UK)

  • Rim Bio (US)

  • Fluids Control (Argentina)

  • Meissner (US)

Bioprocess Containers Industry Developments

April 2022: Thermo Fisher Scientific opened a single-use technology manufacturing site in Ogden, Utah. This creates additional capacity to produce the high-quality technology and materials needed for developing new vaccines and breakthrough therapies, thereby indicating the increased production of bioprocess containers.

July 2021: Cytiva and Pall Corporation invested more than 300.0 million in single-use technologies, including bioreactor bags for growing cells used to make personalized medicines and syringe filters for scientific research.

Bioprocess Containers Market Segmentation

Bioprocess Containers Type Outlook

  • Foam Dressings

  • Film Dressings

  • Hydrocolloid Dressings

  • CHG Adhesive Dressings

  • Alginate Dressing

  • Surgical Tapes

  • Hydrogel Dressings

  • Others

Bioprocess Containers Application Outlook

  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Surgical and Traumatic Wounds

  • Burns

  • Ostomy Care

  • Others

Bioprocess Containers  End Users Outlook

  • Hospitals and Clinics

  • Home Care Settings

  • Others

Bioprocess Containers Regional Outlook

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Report Attribute/Metric Details
Market Size 2022 USD 1.90 billion
Market Size 2023 USD 2.40 billion
Market Size 2032 USD 10.1 billion
Compound Annual Growth Rate (CAGR) 26% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018 & 2020
Market Forecast Units Value (USD Billion)
Report Coverage Market Competitive Landscape, Growth Factors,  Revenue Forecast, and Trends
Segments Covered Type, Application,  End Users, and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, UK, Italy, Germany, France, Spain, India, China, Japan, Australia, South Korea, and Brazil
Key Companies Profiled Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US)
Key Market Opportunities Increasing the use of cost-effective products
Key Market Dynamics High development and manufacturing costs of biologics coupled with expiring patents should increase demand for single-use bioprocessing technologies.

Frequently Asked Questions (FAQ) :

The market size of global Bioprocess Containers was valued at USD 1.90 Billion in 2022.

The global market is projected to grow at a CAGR of 26% during the forecast period, 2023-2032.

North America had the leading share of the global market

The key players in the market are Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), Meissner (US), and others.

The foam 2D Bioprocess Containers category dominated the market in 2021.

The pharmaceutical company's application had the largest global market share.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.